Suven Pharmaceuticals Ltd 543064
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- INR 642.35
- Day Range
- INR 644.40–649.30
- 52-Week Range
- INR 427.05–767.00
- Bid/Ask
- INR 0.00 / INR 0.00
- Market Cap
- INR 164.37 Bil
- Volume/Avg
- 271 / 36,325
Key Statistics
- Price/Earnings (Normalized)
- 46.66
- Price/Sales
- 14.35
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Suven Pharmaceuticals Ltd is engaged in the development and manufacturing of Intermediates, Active Pharmaceutical Ingredients (API), specialty chemicals and formulated drugs under Contract Research and Manufacturing Services (CRAMS) for global pharmaceutical, biotechnology and chemical companies. The company has single operating segment that is Pharmaceuticals Manufacturing & Services and its geographical segments include India; the USA; Europe and the Rest of the World. The company derives a majority of revenue from the Europe segment.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 1,165
- Website
- https://www.suvenpharm.com
Comparables
Valuation
|
Metric
|
543064
|
543748
|
524348
|
|---|---|---|---|
Price/Earnings (Normalized) | 46.66 | 26.06 | 26.49 |
Price/Book Value | 8.45 | 3.17 | 3.52 |
Price/Sales | 14.35 | 3.00 | 1.78 |
Price/Cash Flow | 37.16 | 17.34 | 20.04 |
Price/Earnings
543064
543748
524348
Financial Strength
|
Metric
|
543064
|
543748
|
524348
|
|---|---|---|---|
Quick Ratio | 7.57 | 0.90 | 0.91 |
Current Ratio | 10.40 | 1.94 | 1.66 |
Interest Coverage | 95.74 | 18.46 | 8.03 |
Quick Ratio
543064
543748
524348
Profitability
|
Metric
|
543064
|
543748
|
524348
|
|---|---|---|---|
Return on Assets (Normalized) | — | 9.32% | 7.10% |
Return on Equity (Normalized) | — | 13.35% | 13.89% |
Return on Invested Capital (Normalized) | — | 12.33% | 10.74% |
Return on Assets
543064
543748
524348
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Lxlbyqnk | Ykc | $79.4 Bil | |
MKKGY
| Merck KGaA ADR | Ljrhlnggt | Bmrmgwr | $79.0 Bil | |
HLN
| Haleon PLC ADR | Lsthzjpnw | Wtd | $38.5 Bil | |
VTRS
| Viatris Inc | Xrkvybf | Kwsz | $13.1 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Cgpqlcgx | Xdmtz | $11.7 Bil | |
CTLT
| Catalent Inc | Mjnrqdlp | Zltmhq | $10.0 Bil | |
CURLF
| Curaleaf Holdings Inc | Kfqksfn | Zfbm | $4.2 Bil | |
PRGO
| Perrigo Co PLC | Zrdktgv | Dhhjh | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Fyfhrkjkh | Ymmtslx | $3.2 Bil | |
GTBIF
| Green Thumb Industries Inc | Wcvrjxlfvr | Bpl | $3.1 Bil |